Adverse events1,110

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 1,110

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anaemia	Blood and lymphatic system disorders	Rogaratinib Total Dose Escalation	2	23	2
other	Anaemia	Blood and lymphatic system disorders	Rogaratinib Dose Expansion (All Comers)	4	23	11
other	Anaemia	Blood and lymphatic system disorders	Rogaratinib Dose Expansion (BC)	17	74	29
other	Anaemia	Blood and lymphatic system disorders	Rogaratinib Dose Expansion (SCCHN)	3	8	6
other	Anaemia	Blood and lymphatic system disorders	Rogaratinib Dose Expansion (sqNSCLC)	12	40	19
other	Lymphopenia	Blood and lymphatic system disorders	Rogaratinib Total Dose Escalation	0	23	0
other	Lymphopenia	Blood and lymphatic system disorders	Rogaratinib Dose Expansion (All Comers)	0	23	0
other	Lymphopenia	Blood and lymphatic system disorders	Rogaratinib Dose Expansion (BC)	0	74	0
other	Lymphopenia	Blood and lymphatic system disorders	Rogaratinib Dose Expansion (SCCHN)	0	8	0
other	Lymphopenia	Blood and lymphatic system disorders	Rogaratinib Dose Expansion (sqNSCLC)	2	40	4
other	Neutropenia	Blood and lymphatic system disorders	Rogaratinib Total Dose Escalation	0	23	0
other	Neutropenia	Blood and lymphatic system disorders	Rogaratinib Dose Expansion (All Comers)	2	23	4
other	Neutropenia	Blood and lymphatic system disorders	Rogaratinib Dose Expansion (BC)	0	74	0
other	Neutropenia	Blood and lymphatic system disorders	Rogaratinib Dose Expansion (SCCHN)	0	8	0
other	Neutropenia	Blood and lymphatic system disorders	Rogaratinib Dose Expansion (sqNSCLC)	1	40	1
other	Thrombocytopenia	Blood and lymphatic system disorders	Rogaratinib Total Dose Escalation	0	23	0
other	Thrombocytopenia	Blood and lymphatic system disorders	Rogaratinib Dose Expansion (All Comers)	2	23	5
other	Thrombocytopenia	Blood and lymphatic system disorders	Rogaratinib Dose Expansion (BC)	0	74	0
other	Thrombocytopenia	Blood and lymphatic system disorders	Rogaratinib Dose Expansion (SCCHN)	0	8	0
other	Thrombocytopenia	Blood and lymphatic system disorders	Rogaratinib Dose Expansion (sqNSCLC)	2	40	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01976741/events

API reference For AI assistants

Adverse events1,110

Sources 3

Read this list from software.